Thursday, June 22, 2023 11:24:46 AM
Also Phase 1 Clinical trials for viral loaded CAR-T cells announcement is also imminent. This new treatment process has shown to have 80% to 100% total cure rate for the brain cancer model used on rodents. I wonder who our partners will be for this? :D
This clinical trial annoucement will be the cherry on top of the upcoming announcement for the Phase 3 trial for breast cancer. (who is going to be the partner for this? :D)
The coming weeks and months is ONCY's time to pop off!
This clinical trial annoucement will be the cherry on top of the upcoming announcement for the Phase 3 trial for breast cancer. (who is going to be the partner for this? :D)
The coming weeks and months is ONCY's time to pop off!
Recent ONCY News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 01:03:22 PM
- Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors • GlobeNewswire Inc. • 05/22/2026 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:30:07 PM
- "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies • GlobeNewswire Inc. • 05/14/2026 02:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 01:03:46 PM
- Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer • GlobeNewswire Inc. • 05/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 12:16:41 PM
- Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study • GlobeNewswire Inc. • 04/27/2026 12:10:00 PM
- Form F-10POS - Post-effective amendment to a F-10EF registration • Edgar (US Regulatory) • 04/08/2026 09:04:36 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 04/08/2026 09:03:47 PM
